Claritev (NYSE:CTEV) Stock Has Consensus Target Price of $44.83 According to Analysts

Claritev (NYSE:CTEV) has earned an average rating of “Moderate Buy” from the nine research firms that are covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, two have given a hold rating and six have given a buy rating to the company. The average twelve-month target price among brokerages that have issued ratings on the stock in the last year is $44.83.

Several equities research analysts have issued reports on CTEV shares. Wall Street Zen raised Claritev from a “sell” rating to a “hold” rating in a report on Saturday, August 8th. Barclays reiterated an “overweight” rating and issued a $40.00 price objective (up from $28.00) on shares of Claritev in a report on Thursday, August 20th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Claritev in a report on Monday, September 21st. Citigroup reissued a “buy” rating and issued a $45.00 price objective (up from $40.00) on shares of Claritev in a research report on Monday, August 10th. Finally, Canaccord Genuity Group lifted their target price on shares of Claritev from $37.00 to $43.00 and gave the stock a “buy” rating in a report on Monday, August 10th.

Insider Activity at Claritev

In related news, CEO Travis Dalton acquired 4,500 shares of the business’s stock in a transaction on Thursday, August 27th. The stock was purchased at an average cost of $38.81 per share, for a total transaction of $174,645.00. Following the completion of the transaction, the chief executive officer directly owned 50,372 shares of the company’s stock, valued at approximately $1,954,937.32. The trade was a 9.81% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Tiffani Misencik sold 8,850 shares of the firm’s stock in a transaction that occurred on Friday, August 14th. The stock was sold at an average price of $40.07, for a total transaction of $354,619.50. Following the sale, the senior vice president owned 123,723 shares of the company’s stock, valued at $4,957,580.61. This trade represents a 6.68% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 26,306 shares of company stock valued at $919,372 in the last 90 days. Insiders own 7.40% of the company’s stock.

Hedge Funds Weigh In On Claritev

A number of large investors have recently made changes to their positions in the company. Engineers Gate Manager LP bought a new stake in shares of Claritev in the second quarter valued at about $245,000. Integrated Wealth Concepts LLC acquired a new position in shares of Claritev during the second quarter worth $44,000. Public Investment Fund acquired a new stake in shares of Claritev during the second quarter valued at about $43,703,438. FAS Wealth Partners Inc. boosted its position in Claritev by 49.5% during the 1st quarter. FAS Wealth Partners Inc. now owns 46,477 shares of the company’s stock worth $759,000 after buying an additional 15,380 shares during the period. Finally, Bank of America Corp DE lifted its holdings in shares of Claritev by 146.6% during the first quarter. Bank of America Corp DE now owns 97,795 shares of the company’s stock worth $1,598,000 after purchasing an additional 58,133 shares during the period. Institutional investors own 87.15% of the company’s stock.

Claritev Stock Down 0.3%

CTEV opened at $23.86 on Friday. Claritev has a 12-month low of $11.50 and a 12-month high of $73.68. The business has a 50 day moving average of $31.85 and a 200-day moving average of $27.59. The stock has a market cap of $404.43 million, a price-to-earnings ratio of -1.40 and a beta of 0.93.

Claritev (NYSE:CTEV) last posted its earnings results on Friday, August 7th. The company reported $1.41 earnings per share for the quarter, topping analysts’ consensus estimates of ($4.10) by $5.51. The business had revenue of $257.48 million for the quarter. As a group, analysts expect that Claritev will post -15.13 earnings per share for the current year.

Claritev Company Profile

Claritev is a healthcare technology, data and insights company focused on improving affordability,  transparency and quality. Led by deeply experienced associates, data scientists, and innovators, Claritev provides tech-enabled solutions and services fueled by multiple data sources from over 40 years of claims repricing. Claritev utilizes world-class technology and AI solutions to power a robust enterprise platform that delivers meaningful insights to drive affordability in healthcare, brings price transparency and optimizes networks and benefits design.